Assessment of Ki67 in Breast Cancer: Updated Recommendations From the International Ki67 in Breast Cancer Working Group

Ki67 immunohistochemistry (IHC), commonly used as a proliferation marker in breast cancer, has limited value for treatment decisions due to questionable analytical validity. The International Ki67 in Breast Cancer Working Group (IKWG) consensus meeting, held in October 2019, assessed the current evi...

Descripción completa

Detalles Bibliográficos
Autores principales: Nielsen, Torsten O, Leung, Samuel C. Y, Rimm, David L, Dodson, Andrew, Acs, Balazs, Badve, Sunil, Denkert, Carsten, Ellis, Matthew J, Fineberg, Susan, Flowers, Margaret, Kreipe, Hans H, Laenkholm, Anne-Vibeke, Pan, Hongchao, Penault-Llorca, Frédérique M, Polley, Mei-Yin, Salgado, Roberto, Smith, Ian E, Sugie, Tomoharu, Bartlett, John M. S, McShane, Lisa M, Dowsett, Mitch, Hayes, Daniel F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Commentaries
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8487652/
https://www.ncbi.nlm.nih.gov/pubmed/33369635
http://dx.doi.org/10.1093/jnci/djaa201

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8487652/
https://www.ncbi.nlm.nih.gov/pubmed/33369635
http://dx.doi.org/10.1093/jnci/djaa201

Ejemplares similares